How will European Commission proposals on data exclusivity and the bolar exemption affect pharma companies?
By Andrew Sharples, co-head of EIP’s UK litigation team In April, the European Commission published proposed legislation (specifically a new Regulation and a new Directive)
External Contributor
June 13, 2023